← 產業報告目錄
Novel Drug Delivery Systems In Cancer Therapy Market Size, Share & Trends Analysis Report By Product (Nanoparticles, Embolization Particles), By Region, And by Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-16頁數 175報告編號 INSIGHTACE-b0a03b6b2c
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Novel Drug Delivery Systems In Cancer Therapy Market on a global scale was estimated at USD 12.71 Billion in 2023 and is forecasted to attain USD 63.25 Billion by 2031, with a projected CAGR of 22.41% between 2024 and 2031.
At its core, Novel Drug Delivery Systems In Cancer Therapy pertains to key industry insights & findings from the report:
The ability of novel drug delivery systems to deliver targeted therapies provides opportunities for personalized medicine. Stakeholders across the healthcare landscape are growingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, bolstered by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Novel Drug Delivery Systems in Cancer Therapy Market Snapshot
Chapter 4. Global Novel Drug Delivery Systems in Cancer Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Volume (no. of units) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Nanoparticles
5.2.1.1. Liposomes
5.2.1.2. Polymer
5.2.1.3. Micelles
5.2.1.4. Other nanoparticles
5.2.2. Embolization particles
5.2.2.1. PVA particles
5.2.2.2. Drug-eluting beads
5.2.2.3. Liquid emboli
5.2.2.4. Other embolization particles
Chapter 6. Novel Drug Delivery Systems in Cancer Therapy Market Segmentation 2: Regional Estimates & Trend Analysis
6.1. North America
6.1.1. North America Novel Drug Delivery Systems in Cancer Therapy Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
6.1.2. North America Novel Drug Delivery Systems in Cancer Therapy Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
6.2. Europe
6.2.1. Europe Novel Drug Delivery Systems in Cancer Therapy Market revenue (US$ Million) by Product Type, 2024-2031
6.2.2. Europe Novel Drug Delivery Systems in Cancer Therapy Market revenue (US$ Million) by country, 2024-2031
6.3. Asia Pacific
6.3.1. Asia Pacific Novel Drug Delivery Systems in Cancer Therapy Market revenue (US$ Million) by Product Type, 2024-2031
6.3.2. Asia Pacific Novel Drug Delivery Systems in Cancer Therapy Market revenue (US$ Million) by country, 2024-2031
6.4. Latin America
6.4.1. Latin America Novel Drug Delivery Systems in Cancer Therapy Market revenue (US$ Million) by Product Type, 2024-2031
6.4.2. Latin America Novel Drug Delivery Systems in Cancer Therapy Market revenue (US$ Million) by country, 2024-2031
6.5. Middle East & Africa
6.5.1. Middle East & Africa Novel Drug Delivery Systems in Cancer Therapy Market revenue (US$ Million) by Product Type, 2024-2031
6.5.2. Middle East & Africa Novel Drug Delivery Systems in Cancer Therapy Market revenue (US$ Million) by country, 2024-2031
Chapter 7. Competitive Landscape
7.1. Major Mergers and Acquisitions/Strategic Alliances
7.2. Company Profiles
7.2.1. Teva Pharmaceutical Industries Ltd.
7.2.2. Johnson & Johnson Services, Inc.
7.2.3. GALEN; Merrimack Pharmaceuticals, Inc.
7.2.4. Shire
7.2.5. Samyang Biopharmaceuticals Corporation
7.2.6. Celgene Corporation
7.2.7. Spectrum Pharmaceuticals, Inc.
7.2.8. BTG
7.2.9. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們